Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase

Fig. 2

Tumor suppressors network associated with the BCR-ABL/MAPK pathway. Representation of the tumor suppressors involved in the RAS/MEK/ERK pathway and the JAK2/β-catenin pathway. DOK family proteins are involved in the negative regulation of RAS activation. Representation of the IRF pathway. Finally, morgana/chp-1 pathway is indicated

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us